 The study used a discrete choice experiment methodology to quantify preferences for new injection treatments of patients and physicians with atopic dermatitis, revealing that while both groups preferred the efficacy of improving rashes and itching, physicians were more concerned about cost while patients preferred add-on treatments and were against self-administering the treatment at home. These findings have implications for shared decision-making and clinical practice. This article was authored by Yukorio Kubo, Keryon Ho, Simon Pfeiffer, and others.